ABSTRACT There are a number ofagents which, when added to cultures of murine erythroleukemia cells (MELC), markedly increase the probability of commitment to express the characteristics of terminal erythroid differentiation, including loss of proliferative capacity and increased accumulation of globin mRNA and hemoglobin. Some characteristics of inducer-mediated commitment of MELC to terminal erythroid differentiation were examined by determining the effects of dexamethasone (an inhibitor of inducer-mediated MELC differentiation) and of hemin (an inducer of globin mRNA accumulation). Previously, it was shown that exposure of MELC to hexamethylene-bisacetamide (HMBA) leads to commitment, detectable within 12 hr. MELC cultured with both HMBA and dexamethasone do not express commitment. MELC transferred from culture with HMBA and dexamethasone to cloning medium without these agents express commitment to terminal erythroid differentiation, indicating that MELC retain a "memory" for some early HMBA-mediated changes leading to commitment which occur even in the presence of the inhibitory steroid. The kinetics of commitment in experiments in which exposure to HMBA is interrupted, or dexamethasone is added to the culture with HMBA, suggest that there is a rate-limiting step early in the commitment process. The memory for this step persists for more than one cell cycle. Addition ofhemin to cultures with HMBA and dexamethasone initiates accumulation of globin mRNA but does not reverse the steroid-mediated inhibition of terminal cell division (that is, the cells retain their proliferative capacity). Inducer-mediated MELC commitment is associated with accumu-
Murine erythroleukemia cells (MELC) are virus-transformed erythroid precursor cells that retain the capacity, under in vitro conditions, for self-renewal and for terminal differentiation upon exposure to any ofa number of inducing agents (1) (2) (3) (4) (5) . Till et aL (6) , studying mouse hematopoietic stem cells, suggested that the kinetics of loss of the capacity for self-renewal and terminal differentiation are compatible with a stochastic process involving a random-event component. The kinetics of inducermediated MELC commitment to terminal erythroid differentiation are also compatible with a stochastic process (7, 8) . The mechanism determining the probability of commitment to terminal differentiation is unknown.
Inducing agents, such as dimethyl sulfoxide (Me2SO) (1) and hexamethylenebisacetamide (HMBA) (9) , markedly increase the probability of the event(s) that commits MELC to terminal erythroid differentiation. Induced differentiation of MELC is characterized by the coordinated expression of the program of erythroid differentiation, including initiation of terminal cell division (7, 8) , increased accumulation of a-and P-globin mRNA (10, 11) , of a-, ,Bma.or , and 13minor-globins and hemoglobins (12, 13) , of heme synthesizing enzymes (14) , and ofspectrin (15) . Commitment is defined operationally as the capacity of cells that have been exposed to inducer to initiate their terminal cell divisions and to express other differentiated characteristics in the absence of inducer (8) and is detectable after 12 to 16 hr of culture with inducer (8, 16, 17) ; the lag period in onset and the rate of commitment vary with the type and concentration of inducer.
We (8, 18) and others (19) have obtained evidence to suggest that there are inducer-mediated effects in MELC, associated with commitment, for which the cells retain a "memory" through more than one cell cycle, even ifthe expression ofcommitment is suppressed. For example, the tumor promoter, 12-O-tetradecanoylphorbol 13-acetate (TPA), is a potent inhibitor of HMBA-mediated MELC differentiation. MELC transferred from culture with HMBA and TPA, in which they do not express commitment, to medium without either agent will subsequently display the characteristics of terminal erythroid differentiation (18) .
The present studies were designed to define further some aspects of HMBA-mediated commitment of MELC to terminal erythroid differentiation. These studies, using dexamethasone, an inhibitor of inducer-mediated differentiation (20) (21) (22) (23) (24) , provide evidence that commitment is a multistep process. Inducerdependent initial steps in the commitment process are not sensitive to the steroid; dexamethasone inhibits later steps associated with the initiation of terminal cell division and globin mRNA and hemoglobin accumulation. Commitment to terminal cell division involves steps distinct from the expression of globin genes; addition of hemin to MELC in culture with HMBA and dexamethasone permits the accumulation of globin mRNA but does not reverse the steroid-mediated suppression of commitment to terminal cell division. METHODS MELC cell line DSl9, subcloned from line 745A (provided by Charlotte Friend), was maintained in culture as described (8) . Cells were grown in liquid suspension culture and diluted every 2 days to 105 cells per ml in fresh medium. HMBA (9) was a gift of Charles Pfizer & Co. Cell density and benzidine-reactive cells were assayed as detailed elsewhere (25 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 79 (1982) pension culture with HMBA to medium containing 1.8% methylcellulose without inducer (8 (Fig. 3) Left) or with HMBA and dexamethasone (i; Right) for 48 hr. The cells were then transferred to fresh medium either with (-) or without HMBA (----). As controls, MELW were cultured continuously with HMBA (a-.) or without HMBA (o-o). As additional controls, (data not shown), cells were cultured continuously with or without HMBA and were subjected to washing and resuspension at 12 hr and at 60 hr; the kinetics of commitment were not affected by these manipulations.
minal cell division or hemoglobin accumulation; (ii) later inducer-mediated effects, involving expression of terminal cell division and hemoglobin accumulation, are reversibly suppressed by dexamethasone; and (iii) an early step in the commitment process appears to be rate limiting.
Effect of Hemin on Dexamethasone-Suppressed Globin mRNA Accumulation and Terminal Cell Division. Addition of hemin to MELC cultures induces an increased rate of accumulation ofnewly synthesized a-and ,B3globin mRNA but does not initiate terminal cell division (17, 31) . In the present experiments, MELC were cultured with HMBA, with HMBA and dexamethasone, with HMBA, dexamethasone, and hemin, and with hemin alone. Addition of hemin to cultures with inducer and steroid was associated with accumulation of newly synthesized a-globin mRNA to about the same level as observed in cells cultured with HMBA alone (Table 2) . Addition of hemin did not affect dexamethasone-mediated inhibition of HMBAinduced commitment to terminal cell division.
Changes in Chromatin Protein Associated with HMBA-Mediated MELC Commitment. Eisen and coworkers (29) reported a chromatin-associated protein, IP25, which appears early during induced differentiation in vitro. They suggested that this protein plays a role in the control of proliferation and differentiation of MELC, as well as other cell types (29, 32 ). IP25 appears to be identical to the chromatin protein, Hlo, described earlier by Panyim and Chalkley (33) . To examine the relationship between the accumulation of IP25 and inducer-mediated 
DISCUSSION
These studies provide evidence that HMBA-mediated MELC commitment to terminal erythroid cell differentiation is a multistep process. The evidence includes: (i) the observation that some inducer-mediated changes early in the process of commitment are not suppressible by dexamethasone, whereas later steps, involving initiation of terminal cell division and globin mRNA synthesis, are sensitive to this steroid; (ii) the rate-limiting step in commitment appears to be in the early stage of the process; (iii) later steps in the expression of commitment occur relatively rapidly; and (iv) MELC can retain a memory for prior exposure to HMBA which can persist, without expression of terminal cell division or ofthe globin genes, for up to 24 hr. The molecular basis of this memory is unknown, but this inducermediated change is associated with an early stage of the commitment process and can persist through more than one cell cycle, because the generation time for MELC is 11-12 hr (17) .
In earlier studies, the tumor promotor TPA, another potent inhibitor of inducer-mediated MELC differentiation (18) , was also found to suppress terminal cell division and accumulation of newly synthesized globin mRNA and hemoglobin formation but not the memory for inducer-mediated changes that could lead to commitment. It would appear that a late step in the commitment process is the target for the suppression of terminal differentiation observed with both the tumor promoters, such as TPA, and the steroid dexamethasone. These observations do not necessarily mean that these agents act at the same molecular site.
Studies of inducer-mediated MELC differentiation (34) (35) (36) (37) (38) (39) and a number of other differentiating cell systems (40) (41) (42) (43) (44) , including normal erythropoiesis (45) (46) (47) , suggest that DNA synthesis is required for the transition to expression of differentiated characteristics. For example, we found that inducermediated events during early S phase appear to be required for the expression of a-and ,3-globin genes in MELC cultured with HMBA (37, 38) . Conkie et aL (39) , working with a temperaturesensitive variant of MELC, found that, under conditions nonpermissive for cell division, MELC could not be induced to erythroid differentiation. On the other hand, it has been suggested that inducer-mediated MELC commitment is unaffected by inhibition of DNA synthesis (48, 49) . These studies are difficult to interpret, owing to the fact that cells were either cultured in the presence ofinducer for a protracted period prior to addition of inhibitor or that the inhibitor used, such as hydroxyurea, does not completely block DNA synthesis and does itself induce MELC differentiation (2) .
The evidence for a requirement for DNA synthesis for inducer-mediated commitment of MELC may reflect the need to restructure chromatin during commitment. The present study confirms (29, 31, 32) that inducer-mediated MELC commitment is associated with a change in the accumulation of IP25. The accumulation of this chromatin protein, however, is not sufficient for inducer-mediated expression ofterminal erythroid cell differentiation. The possibility that inducer-mediated restructuring of chromatin configuration may be one step in the commitment process requires further investigation.
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